ESR1 and breast carcinoma: These findings underscore the need for a nuanced understanding of kisspeptin/kisspeptin receptor signaling in breast cancer, as its role appears to be context-dependent and influenced by factors such as estrogen receptor status and interaction with other cellular pathways [16].